SBIR Phase II: Characterization of the Metabolic Competency of Centrifugal Bioreactors

这个小企业创新研究二期项目是开发一个中试规模的离心生物反应器（CBR），用于杂交瘤细胞的连续培养。该项目的商业应用将在生物制药工业中用于细胞培养生产治疗剂。预计该技术将减少商业化动物细胞培养设备的规模和资金成本，并提高分泌蛋白产品的质量和一致性。

This Small Business Innovation Research Phase II project is to develop a pilot-scale Centrifugal Bioreactor (CBR) for the continuous cultivation of hybridoma cells. The commercial application of this project will be in the biopharmaceutical industry for cell culture production of therapeutic agents. It is expected that the technology will reduce the scale and capital costs of commercial animal cell culture equipment and improve the quality and consistency of the secreted protein product.